Concepedia

Zongliang Lu

ZL

11

Publications

359

Citations

11

H-Index

2013

Active since

Affiliations

Daping Hospital(Current)

Army Medical University

Chongqing Medical University

Chinese People's Liberation Army

Zongliang Lu is an author at Daping Hospital specializing in urology, cell death mechanisms, and tumor biology.

Top concepts

Publications per year

2013–2022

11

Publications

11

S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway

Zongliang Lu, Rui Zhou, Ya Kong et al. · Current Cancer Drug Targets · 2016 · 59 citations

Ophiopogonin D' induces RIPK1‑dependent necroptosis in androgen‑dependent LNCaP prostate cancer cells

Zongliang Lu, Chang-Peng Wu, Mingxing Zhu et al. · International Journal of Oncology · 2019 · 40 citations · Full text

, , +20

Ophiopogonin D′, a Natural Product From Radix Ophiopogonis, Induces in Vitro and in Vivo RIPK1-Dependent and Caspase-Independent Apoptotic Death in Androgen-Independent Human Prostate Cancer Cells

Zongliang Lu, He Wang, Mingxing Zhu et al. · Frontiers in Pharmacology · 2018 · 38 citations · Full text

Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese <i>ob/ob</i> mice

Jing Guo, Mengyuan Zhang, He Wang et al. · Journal of Food Biochemistry · 2022 · 38 citations

Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo

Rui Zhou, Zongliang Lu, Kai Liu et al. · Current Cancer Drug Targets · 2015 · 36 citations · Full text

Rows per page

1–5 of 11